Schecter R - Search Results

1

Sequencing of disease-modifying therapies for relapsing-remitting multiple sclerosis: a theoretical approach to optimizing treatment.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R. Grand'Maison F, et al. Among authors: schecter r. Curr Med Res Opin. 2018 Aug;34(8):1419-1430. doi: 10.1080/03007995.2018.1458023. Epub 2018 Apr 18. Curr Med Res Opin. 2018. PMID: 29583054 Review.

2

The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis.

Freedman MS, Duquette P, Grand'Maison F, Lee L, Vorobeychik G, Lara N, Khurana V, Nakhaipour HR, Schecter R, Haddad P. Freedman MS, et al. Among authors: schecter r. Curr Med Res Opin. 2019 May;35(5):767-776. doi: 10.1080/03007995.2019.1565818. Epub 2019 Jan 21. Curr Med Res Opin. 2019. PMID: 30614288

3

Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches.

Grand'Maison F, Yeung M, Morrow SA, Lee L, Emond F, Ward BJ, Laneuville P, Schecter R. Grand'Maison F, et al. Among authors: schecter r. Neural Regen Res. 2018 Nov;13(11):1871-1874. doi: 10.4103/1673-5374.239432. Neural Regen Res. 2018. PMID: 30233054 Free PMC article. Review.

4

Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.

Lapierre Y, O'Connor P, Devonshire V, Freedman MS, Kremenchutzky M, Yeung M, Schecter R. Lapierre Y, et al. Among authors: schecter r. Can J Neurol Sci. 2016 Mar;43(2):278-83. doi: 10.1017/cjn.2015.325. Epub 2016 Jan 25. Can J Neurol Sci. 2016. PMID: 26890887

5

A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies.

Duquette P, Yeung M, Mouallif S, Nakhaipour HR, Haddad P, Schecter R. Duquette P, et al. Among authors: schecter r. PLoS One. 2019 Jan 14;14(1):e0210417. doi: 10.1371/journal.pone.0210417. eCollection 2019. PLoS One. 2019. PMID: 30640935 Free PMC article.

6

Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada.

Nakhaipour HR, Vudumula U, Khurana V, Sébire G, Mah JK, Pohl D, Schecter R, Adlard N. Nakhaipour HR, et al. Among authors: schecter r. J Med Econ. 2020 Dec;23(12):1525-1533. doi: 10.1080/13696998.2020.1840138. Epub 2020 Nov 12. J Med Econ. 2020. PMID: 33079578 Free article.

7

Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.

Duquette P, Giacomini PS, Bhan V, Hohol M, Schecter R. Duquette P, et al. Among authors: schecter r. Can J Neurol Sci. 2016 Jan;43(1):33-43. doi: 10.1017/cjn.2015.302. Epub 2015 Nov 27. Can J Neurol Sci. 2016. PMID: 26611431 Review.

8

Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE).

Gauthier S, Juby A, Dalziel W, Réhel B, Schecter R; EXPLORE investigators. Gauthier S, et al. Among authors: schecter r. Curr Med Res Opin. 2010 May;26(5):1149-60. doi: 10.1185/03007991003688888. Curr Med Res Opin. 2010. PMID: 20230208

9

Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study.

Gauthier S, Robillard A, Cohen S, Black S, Sampalis J, Colizza D, de Takacsy F, Schecter R; EMBRACE investigators. Gauthier S, et al. Among authors: schecter r. Curr Med Res Opin. 2013 Aug;29(8):989-1000. doi: 10.1185/03007995.2013.802230. Epub 2013 May 23. Curr Med Res Opin. 2013. PMID: 23647369

10

Diagnosis and management of secondary-progressive multiple sclerosis: time for change.

Oh J, Alikhani K, Bruno T, Devonshire V, Giacomini PS, Giuliani F, Nakhaipour HR, Schecter R, Larochelle C. Oh J, et al. Among authors: schecter r. Neurodegener Dis Manag. 2019 Dec;9(6):301-317. doi: 10.2217/nmt-2019-0024. Epub 2019 Nov 26. Neurodegener Dis Manag. 2019. PMID: 31769344 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters